Stage IV Breast Cancer: Magnolia's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- Mastectomy.
- Chemotherapy.
- Radiation therapy.
- Hormone therapy continued after active treatment.
What happened, in summary
Magnolia, from Colombia, was diagnosed with stage IV breast cancer after noticing a hard breast mass. Her menstrual periods had stopped at age 45, and the symptoms developed over several months before she sought medical care. The diagnosis left her frightened, nervous, and worried, but she wanted to begin treatment quickly.
Her care included mastectomy, chemotherapy, radiation therapy, and hormone therapy. She did not seek a second opinion and followed the recommended plan. Treatment caused hair loss, lymphedema, nausea, and vomiting. She managed these effects with prescribed medication and improved nutrition. Cancer also created financial strain after she lost her job while continuing to pay household and housing costs.
In March 2022, Magnolia was declared cancer-free. She described herself as remaining in remission while continuing hormone therapy. Fear of recurrence still affected her, and support from psychologists and psychiatrists helped her cope. She also became more focused on healthier eating, emotional well-being, and time with her family. She contacted her parents more often, spent more time with her children, and hoped to travel with them through the Colombian countryside. Her experience combined ongoing fear with courage, gratitude, faith, and hope.
Where this story comes from
This is a lay summary of an account first published by Our Cancer Stories. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer